Elcon Drugs And Formulations Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 7.72 M
- Company Age 31 Year, 29 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
- Satisfied Charges ₹ 5.85 Cr
- Revenue Growth 623.06%
- Profit Growth 672.72%
- Ebitda 3300.63%
- Net Worth 375.63%
- Total Assets 1281.72%
About Elcon Drugs And Formulations
Elcon Drugs And Formulations Limited (EDAFL) is a leading Public Limited Indian Non-Government Company incorporated in India on 04 January 1994 and has a history of 31 years. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 7.72 M.
The company currently has active open charges totaling ₹3.00 M. The company has closed loans amounting to ₹5.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Khandelwal, Anuradha Khandelwal, and Shiven Khandelwal serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232RJ1994PLC007922
-
Company No.
007922
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
04 Jan 1994
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
What products or services does Elcon Drugs And Formulations Limited offer?
Elcon Drugs And Formulations Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Common Disease Medicines, Antihistamines, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Vitamin Tablets & Capsules, Multivitamin Tablets & Capsules, Diabetic Herbal Medicine, Weight Loss Supplement.
Who are the key members and board of directors at Elcon Drugs And Formulations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuradha Khandelwal
|
Whole-Time Director | 15-Jul-2015 | Current |
|
Amit Khandelwal
|
Whole-Time Director | 04-Jan-1994 | Current |
|
Shiven Khandelwal
|
Director | 25-Jan-2020 | Current |
Financial Performance of Elcon Drugs And Formulations.
Elcon Drugs And Formulations Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 623.06% increase. The company also saw a substantial improvement in profitability, with a 672.72% increase in profit. The company's net worth Soared by an impressive increase of 375.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elcon Drugs And Formulations?
In 2023, Elcon Drugs And Formulations had a promoter holding of 99.85% and a public holding of 0.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹58.50 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jan 2001 | State Bank Of India | ₹3.00 M | Open |
| 30 Sep 2017 | Others | ₹2.25 Cr | Satisfied |
| 29 Feb 2016 | Tata Capital Financial Services Limited | ₹2.00 Cr | Satisfied |
| 15 Oct 2004 | State Bank Of India | ₹2.70 M | Satisfied |
| 15 Oct 2004 | State Bank Of India | ₹0.80 M | Satisfied |
How Many Employees Work at Elcon Drugs And Formulations?
Elcon Drugs And Formulations has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elcon Drugs And Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elcon Drugs And Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
